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1. Introduction 
The inhibitory effects of methemoglobin on acti- 
vation of coronary arterial soluble guanylate cyclase 
by nitric oxide (NO), nitroprusside and N-methyl- 
N’nitro-N-nitrosoguanidine (MNNG) were described 
in [ 11. Also dithiothreitol (DTT) enhanced activation 
of coronary arterial and hepatic soluble guanylate 
cyclase by nitroprusside and MNNG but not by NO, 
and reversed the methemoglobin blockade of acti- 
vation by nitroprusside and MNNG but not by NO. 
Indeed, DTT was required for hepatic guanylate 
cyclase activation by nitroprusside. These observations 
suggested that DTT may react directly with the 
nitroso compounds to promote release of NO, which 
may then overcome the inhibition by methemoglobin 
[ 11. An alternative explanation for the effects of DTT 
on guanylate cyclase activation was a direct non- 
enzymatic transfer of the NO-moiety from the nitroso 
compound to guanylate cyclase (or a ferroheme inter- 
mediate) in the presence of thioB. 
Each of the above hypotheses was tested and the 
data here illustrate that: 
(1) Thiols promote release of NO gas from MNNG, 
but not from nitroprusside, in aqueous neutral 
buffer. 
(2) Inhibition of guanylate cyclase activation by NO 
varies directly with the concentration of methe- 
moglobin and indirectly with the amount of NO. 
(3) Thiols react with NO to form stable S-nitroso- 
thiols which are potent activators of guanylate 
cyclase .
2. Materials and methods 
Guanylate cyclase activity was determined in 
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soluble fractions prepared from bovine coronary 
artery and rat liver by measuring the formation of 
cyclic GMP from GTP, using Mg2+ as the required 
divalent cation, according to [2]. GTP was 0.1 mM 
and 0.3 mM for reaction mixtures containing coronary 
arterial and hepatic soluble fractions, respectively. 
Soluble fractions from bovine coronary artery and rat 
liver were prepared exactly as in [ 1?3] and stored at 
-80°C. Nitroprusside, thiols, heme proteins, ferri- 
cyanide and methylene blue were purchased from 
Sigma, and MNNG was from Aldrich. 
S-Nitrosothiols were synthesized by reacting O2 - 
free solutions of each thiol in 50 mM Tris-HCl 
(pH 7.4) at 4°C for 15 min with purified NO gas 
(99.9%, Matheson gas) in an O2 -free N2 atmosphere 
[4,5]. Unreacted NO was completely removed by 
alternating cycles of vacuum evacuation and N2 
flushing. After reaction with NO, solutions of 
cysteine, N-acetyl cysteine, GSH, DTT and P-D- 
thioglucose turned from clear to a yellow-rose color, 
and the penicillamine solution turned green [4-61. 
Absorption maxima of 1 O-SO mM thiol solutions 
after reaction with NO were 540-550 nm (DTT, 
/3-D-thioglucose), 550-560 nm (cysteine, iV-acetyl 
cysteine, GSH) and 590-600 nm (penicillamine). 
Values for the S-nitroso derivatives of cysteine, GSH, 
DTT, and penicillamine are in excellent agreement 
with reported values [4,6]. Formation of S-nitroso 
derivatives of N-acetyl cysteine and /3-D-thioglucose 
has not been reported yet. 
3. Results and discussion 
DTT enhanced the activation of coronary arterial 
and hepatic guanylate cyclase by nitroprusside and 
MNNG but not by NO [l]. Similarly, cysteine, GSH, 
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and penicillamine enhanced guanylate cyclase acti- 
vation by nitroprusside, MNNG, and NaNOz but not 
by NO. For example, employing coronary arterial 
guanylate cyclase, 0.1 mM nitroprusside or MNNG 
stimulated the formation of 408-482 pmol cyclic 
GMP . min-’ . mg protein-‘, whereas 3 mM NaNOz 
did not alter basal activity (5-8 pmol cyclic 
GMP . min-’ . mg protein-‘). In the presence of 5 mM 
cysteine, GSH or penicillamine, activation (pmol 
cyclic GMP . min-’ . mg protein-’ ) by nitroprusside 
(799-908), MNNG (807-945) and NaNOz (531- 
880) was markedly enhanced. 
DTT reversed or abolished the methemoglobin 
blockade of guanylate cyclase activation by nitro- 
prusside and MNNG but not by NO [ 11. Similarly, 
methemoglobin blockade was reversed with cysteine, 
GSH or penicillamine (unpublished). An explanation 
proposed earlier for such observations was that thiols 
may enhance release of NO from nitroso compounds 
and the increased amount of NO may then overcome 
the inhibitory effect of methemoglobin [ 11. Consis- 
tent with this proposal, fig.1 illustrates that increasing 
concentrations of methemoglobin, hemoglobin or 
myoglobin produced proportionally greater inhibition 
of guanylate cyclase activation by NO, and that 
greater amounts of NO overcame the inhibitory effect 
of the heme proteins. One explanation of the enhance- 
ment, and the reversal of methemoglobin blockade, of 
guanylate cyclase activation by thiols is that the latter 
interact with nitroso compounds or NaNOa to 
liberate NO gas. Therefore, experiments were con- 
ducted to determine the effects of thiols on NO gas 
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Fig.1. Inhibitory effects of heme proteins on activation of 
bovine coronary arterial soluble guanylate cyclase by NO. 
Reaction mixtures (0.1 mM GTP, 3 mM Mg*‘, 85-150 c(g 
soluble tissue protein) were incubated for 10 min at 37°C. 
Heme proteins (MET-Hb, methemoglobin; Hb, hemoglobin) 
were present in reaction mixtures at initiation of reactions 
with enzyme fraction whereas NO was delivered at exactly 
1 min incubation [ 1,2]. Basal activity was 6-9 pmol cyclic 
GMP min-’ . mg protein-‘. Data represent he mean ? SE, 
n=6. 
release from neutral aqueous solutions of nitro- 
prusside and MNNG. The data in table 1 indicate that 
whereas cysteine, DTT, and GSH promoted the 
release of NO gas from MNNG, these thiols either 
decreased or trapped the NO gas released spontane- 
ously from nitroprusside. NaNOs did not release NO 
gas in the absence or presence of the same concen- 
trations of thiols (data not shown). In order to 
generate detectable amounts of NO gas into the upper 
Table 1 
Release of NO gas from nitroprusside (NP) and MNNG in the absence and presence of thiols, 
as detected by guanylate cyclase activation 
Nitroso Sample pmol cyclic GMP . min-’ . mg protein-’ 
compound vol. (/.d) 
Alone 20 mM Cysteine 20 mM DTT 20 mM GSH 
1OmMNP 10 31r 2 7c 3 6* 1 6+- 2 
30 226 + 63 4k 1 7? 3 161 * 7 
100 575 f 27 536 f 50 462 + 17 577 + 36 
10 mM MNNG 10 7? 2 219 * 14 9k 2 7k 3 
30 7+ 3 431 * 17 16* 4 681 + 28 
100 18+- 5 706 r 8 244 f 16 790 * 33 
Reactions between nitroso compounds and thiols were conducted in 3 ml of 100 mM Tris-HCl 
(pH 7.4) for 30 min at 25°C under an atmosphere (2.5 ml) of O,-free N,. Gaseous amples were 
delivered to guanylate cyclase reaction mixtures (0.1 mM GTP, 3 mM Mg*+ and 75-90 c(g 
soluble bovine coronary arterial protein) which were incubated for 10 min at 37’C [ 11. Basal 
activity was 4-7 pmol cyclic GMP . mine1 .mg protein-‘. Datarepresent the mean + SE, n = 3-6 
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atmosphere of reaction vessels, concentrations of study. The various S-nitrosothiols prepared markedly 
reactants used in the experiments of table 1 were activated coronary arterial and hepatic soluble 
greater than those used in standard guanylate cyclase guanylate cyclase (table 2). Although table 2 presents 
reaction mixtures. NO gas release in these experiments data obtained with lo-50 PM S-nitrosothiols, only 
was assayed by comparing effects of the gaseous 0.1-I PM S-nitroso derivatives of cysteine, penicil- 
phase of reaction mixtures to those of purified NO on lamine, and /3-D-thioglucose activated guanylate 
guanylate cyclase activation and coronary arterial cyclase (224-935 pmol cyclic GMP . min-’ . mg pro- 
relaxation in the absence and presence of methemo- tein-‘). Other thiols which formed active S-nitro- 
globin and methylene blue, both of which inhibit sothiols were fl-mercaptoethylamine, 3-mercaptopro- 
these effects of NO [2,7]. The above data suggest hat pionic acid, thioacetic acid and /3-mercaptoethanol. 
thiol enhancement of guanylate cyclase activation by Active compounds were not formed from reactions of 
MNNG but not by nitroprusside or NaNOz may be NO with cystine, GSSG, oxidized DTT, S-methyl- 
due, at least in part, to increased liberation of NO gas cysteine, cysteic acid, 5-thioglucose, L-serine or 
through direct chemical interaction of thiol and L-alanine, none of which possess free sulfhydryl 
MNNG. moieties. 
The findings that thiols: 
(i) Enhanced guanylate cyclase activation by nitro- 
prusside and NaNO,; 
(ii) Did not promote release of NO gas from nitro- 
prusside or NaNOz; 
(iii) May have trapped NO gas released from nitro- 
prusside (table 1); 
suggested that thiols reacted with nitroso compounds 
or NaN02 to form S-nitrosothiols, which then acti- 
vated guanylate cyclase. Indeed, formation of S-nitro- 
socysteine from cysteine plus either NaNO? [6] or 
MNNG [S] in aqueous solution has been reported. 
S-Nitrosothiols are easily synthesized by reacting 
thiols with either NaNO* at acid pH [6] or NO at 
neutral pH [4,5]. The latter method was used in this 
The observations that S-nitrosothiols are potent 
activators of guanylate cyclase and are formed by 
reaction of thiols with NO [4,5], NaNO, [6], and 
MNNG [5] suggest hat enhancement of guanylate 
cyclase activation by nitroprusside, MNNG and 
NaNOz in the presence of thiols may be through for- 
mation of S-nitrosothiol intermediates. Formation of 
S-nitrosothiols may also explain the thiolinduced 
reversal of methemoglobin blockade of guanylate 
cyclase activation by nitroprusside and MNNG, 
because enzyme activation by S-nitrosothiols was 
much more resistant than that by NO to methemo- 
globin blockade (table 3, fig.1). However, the oxidant 
ferricyanide inhibited guanylate cyclase activation by 
S-nitrosothiols (table 3) or NO [2] equally well, thus 
Table 2 
Activation of soluble guanylate cyclase from bovine coronary artery and rat 
liver by S-nitrosothiols 
S-Nitroso derivative 
01M) 
pmol cyclic GMP . min-’ . mg protein“ 
Coronary artery Liver 
None (basal activity) 8* 0.2 5 * 0.1 
Cysteine (10) 917 f 26 1215 * 54 
GSH (10) 764 * 31 524k18 
DTT (50) 728 2 33 1110+46 
Penicillamine (10) 993 + 25 1632 f 42 
N-Acetyl cysteine (10) 588 + 19 605 f 24 
@-D-Thioglucose (10) 684 + 21 1633+48 
Reaction mixtures for coronary arterial guanylate cyclase contained 0.1 mM 
GTP, 3 mM Mg*‘, 75-95 fig soluble tissue protein and were incubated for 10 min 
at 37°C. Those for hepatic guanylate cyclase contained 0.3 mM GTP, 3 mM 
MgZ: 350-406 pug soluble tissue protein and were incubated for 5 min at 37°C. 
Reactions were initiated by addition of enzyme fraction followed immediately 
with S-nitrosothiol. Data represent he mean f SE, n=4-6 
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Table 3 
Effects of methemoglobin and ferricyanide on activation of bovine coronary 
arterial soluble guanylate cyclase by S-nitrosothiols 
Additions pmol cyclic GMP min-’ . mg protein-’ 
S-Nitroso derivative 
Cysteine (10 PM) Penicillamine (10 PM) DTT (50 /AM) 
None 8412 29 814 f 21 536 + 21 
Methemoglobin 
2pM 141% 34 809 f 22 518 + 18 
10/~M 593 f. 38 129+31 446 + 16 
25 /AM 378 f 30 498 * 41 412 + 22 
Ferricyanide 
50 /.rM 14+ 2 125 1 12* 2 
Reaction mixtures (0.1 mM GTP, 3 mM Mg’+, 82 Mg soluble tissue protein) were 
incubated for 10 min at 37°C. Methemoglobin and ferricyanide were present in 
reaction mixtures at initiation of reactions with enzyme fraction whereas S-nitro- 
sothiols were added immediately after enzyme. Basal activity was 4-7 pmol 
cyclic GMP . min-’ mg protein-‘. Data represent he mean f SE, n=4-6 
suggesting that enzyme activation by these different 
forms of NO involves a common mechanism, which 
may be direct or possibly through formation of a 
nitrosyl-ferroheme complex [8]. In contrast to 
effects on nitroprusside, MNNG and NaNOz, thiols 
failed to enhance guanylate cyclase activation by NO 
and to reverse methemoglobin blockade of NO 
activation [ 11. Although S-nitrosothiols are formed 
during exposure of thiols to large amounts of NO 
under anaerobic conditions, only negligible amounts 
of S-nitrosothiols are likely formed during the brief 
exposure of guanylate cyclase reaction mixtures con- 
taining added thiols to small amounts (0.1 ~1) of NO 
under aerobic conditions. 
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